GRANDE PHARMACIE DE GENAS : revenue, balance sheet and financial ratios

GRANDE PHARMACIE DE GENAS is a French company founded 24 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in GENAS (69740), this company of category PME shows in 2022 a revenue of 3.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE DE GENAS (SIREN 438800799)
Indicator 2024 2023 2022 2019 2018 2017 2016
Revenue N/C N/C 3 827 087 € 1 129 363 € 1 388 979 € 1 594 353 € 1 569 380 €
Net income 107 115 € 51 493 € 182 239 € -37 405 € -82 059 € 26 802 € 9 340 €
EBITDA N/C N/C 295 568 € 14 636 € -8 132 € 37 966 € 42 427 €
Net margin N/C N/C 4.8% -3.3% -5.9% 1.7% 0.6%

Revenue and income statement

In 2024, GRANDE PHARMACIE DE GENAS generates positive net income of 107 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 9 k€ -> 107 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

107 115 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 785%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

785.297%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

10.113%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

52.5%

Solvency indicators evolution
GRANDE PHARMACIE DE GENAS

Sector positioning

Debt ratio
785.3 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of GRANDE PHARMACIE DE GENAS (785.30) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
10.11% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of GRANDE PHARMACIE DE GENAS (10.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
11.62 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average

In 2022, the repayment capacity of GRANDE PHARMACIE DE GENAS (11.62) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 208.57. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

208.567

Liquidity indicators evolution
GRANDE PHARMACIE DE GENAS

Sector positioning

Liquidity ratio
208.57 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good -6 pts over 3 years

In 2024, the liquidity ratio of GRANDE PHARMACIE DE GENAS (208.57) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
3.49x 2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good

In 2022, the interest coverage of GRANDE PHARMACIE DE GENAS (3.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
GRANDE PHARMACIE DE GENAS

Positioning of GRANDE PHARMACIE DE GENAS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of GRANDE PHARMACIE DE GENAS is estimated at 1 495 404 € (range 1 041 376€ - 2 237 210€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1041k€ 1495k€ 2237k€
1 495 404 € Range: 1 041 376€ - 2 237 210€
NAF 5 année 2024

Valuation method used

Net Income Multiple
107 115 € × 14.0x = 1 495 405 €
Range: 1 041 376€ - 2 237 211€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE DE GENAS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE DE GENAS

What is the revenue of GRANDE PHARMACIE DE GENAS ?

The revenue of GRANDE PHARMACIE DE GENAS in 2022 is 3.8 M€.

Is GRANDE PHARMACIE DE GENAS profitable?

Yes, GRANDE PHARMACIE DE GENAS generated a net profit of 107 k€ in 2024.

Where is the headquarters of GRANDE PHARMACIE DE GENAS ?

The headquarters of GRANDE PHARMACIE DE GENAS is located in GENAS (69740), in the department Rhone.

Where to find the tax return of GRANDE PHARMACIE DE GENAS ?

The tax return of GRANDE PHARMACIE DE GENAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE DE GENAS operate?

GRANDE PHARMACIE DE GENAS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.